| Aa-012M7B997-E133-2022 Medicamentos Insabi | 658.7M | 2023-01-01 |
| Adjudicación Directa Aa-012000991-E70-2020 Cons. (Ce-051Gyn007-E37-2020) | 652.9M | 2020-04-18 |
| Adjudicación Directa Aa-012M7B997-E133-2022 Cons. (Ce-051Gyn007-E66-2022) | 545.2M | 2023-01-01 |
| La-12-M7B-012M7B997-I-1-2023 Medicamentos y Material de Curación | 318.6M | 2023-01-31 |
| Adjudicación Directa Aa-012M7B997-E133-2022 Cons. (Ce-051Gyn007-E66-2022) | 238.2M | 2023-01-01 |
| Consolidada de Medicamentos Oncologicos | 218.4M | 2020-04-30 |
| Aa-050Gyn007-E22-2020 Medicamentos | 215.9M | 2020-04-01 |
| Aa-12-512-012000991-T-176-2023 Medicamentos-Salud | 198.5M | 2024-01-01 |